Dexketoprofen trometamol

CAS No. 156604-79-4

Dexketoprofen trometamol( —— )

Catalog No. M23677 CAS No. 156604-79-4

Dexketoprofen trometamol is a modified non-selective COX inhibitor with a rapid onset of action that is available as both oral and parenteral formulations.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 37 In Stock
10MG 61 In Stock
25MG 107 In Stock
50MG 160 In Stock
100MG 226 In Stock
200MG 334 In Stock
500MG 547 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dexketoprofen trometamol
  • Note
    Research use only, not for human use.
  • Brief Description
    Dexketoprofen trometamol is a modified non-selective COX inhibitor with a rapid onset of action that is available as both oral and parenteral formulations.
  • Description
    Dexketoprofen trometamol is a modified non-selective COX inhibitor with a rapid onset of action that is available as both oral and parenteral formulations.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX-2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    156604-79-4
  • Formula Weight
    375.42
  • Molecular Formula
    C20H25NO6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (266.37 mM)
  • SMILES
    O=C(C1=CC=CC([C@H](C)C(O)=O)=C1)C2=CC=CC=C2.OCC(CO)(CO)N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hanna M , Moon J Y . A review of dexketoprofen trometamol in acute pain[J]. Current Medical Research and Opinion, 2018:1-32.
molnova catalog
related products
  • Sulindac

    Sulindac is a nonsteroidal anti-inflammatory agent (NSAIA) of the arylalkanoic acid class that is marketed in the U.S. by Merck as Clinoril.

  • COX-2-IN-34

    COX-2-IN-34 is a selective, orally potent COX-2 inhibitor that shows anti-inflammatory activity without gastric ulcer toxicity during experiments in mice.

  • Firocoxib

    Firocoxib is a selective non-steroidal inhibitor of cycooxygenase-2 (COX-2) (IC50 of 0.13 μM), with anti-inflammatory for use in dogs and horses.